2022

January

  • Marco Colonna, MD
    $172,500 from Cure Alzheimer’s Fund for “Understanding the Role of Natural Ab-Specific B Cell Responses in AD Progression”
    $107,258 from Aclaris Therapeutics for “Study of Gut-Selective vs. Systemic Jak Inhibitors in Pre-Clinical Models of IBD”
  • Kodi Ravichandran, PhD
    $583,731 from NIH for “Solute carrier proteins in efferocytosis and inflammation”
    $334,393 from NIH for “Mechanisms regulating apoptotic cell clearance in health and disease”
  • Steven L. Teitelbaum, MD
    $457,219 from NIH for “Hepatic steatosis promotes liver metastasis”
  • Parker Wilson, MD, PhD
    $167,826 from NIH for “The Single Cell Landscape of Early Human Diabetic Nephropathy”

February

  • Marco Colonna, MD
    $624,511 from NIH for “Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity”
  • Ali Ellebedy, PhD
    $354,375 from NIH for “Structural interrogation of vaccine- and infection-induced B cell responses”
  • Gwendalyn Randolph, PhD
    $544,177 from NIH for “Mechanisms that alter lymphatic transport in inflammatory bowel disease”
  • Emil Unanue, MD
    $471,535 from NIH for “ADMR – Autoimmune Diabetes: Macrophage Responses”

March

  • Maxim Artyomov, PhD
    $128,178 from Genentech for “Stochastic simulations of TCR-MHC interactions”
    $321,271 from Aging Biology Foundation for “Aging Human Tissues Systems Level Dissection of Immune Aging”
    $446,357 from Aging Biology Foundation for “Personnel Systems Level Dissection of Human Aging”
  • Ali Ellebedy, PhD
    $148,226 from NIH for “Understanding the Impact of Imprinting and Repeat Antigen Exposure on Durability of Antibody Responses to the Influenza Virus”
  • Ta-Chiang Liu, MD, PhD
    $34,085 from NIH for “Paneth Cell Heterogeneity in Infection and Inflammation”
    $160,001 from Interline Therapeutics for “Developing a translational understanding of high impact genetic variants in inflammatory bowel disease”
  • Bernd H. Zinselmeyer, PhD
    $30,000 from Genentech for “Characterizing the impact of CD2AP and CIN85 on Leucocyte motility in real time in vivo”

April

  • Gautam Dantas, PhD
    $60,000 from The Foundation For Barnes-Jewish Hospital for “CTRFP Strain tracking and genomic characterization of Pseudomonas aeruginosa across clinical and environmental samples in the BJH healthcare system”
  • Brian Edelson, MD, PhD
    $236,250 from NIH for “Selective induction of alloantigen-specific humoral tolerance by MHC-Fc fusion proteins”
  • Jonathan Kipnis, PhD
    $345,000 from Cure Alzheimer’s Fund for “Berg Brain Entry & Exit Consortium: Crosstalk of CNS barriers and clearance routes in homeostasis and Alzheimer’s disease”
  • Melanie L. Yarbrough, PhD
    $110,076 from bioMerieux for “bioMerieux IIR Program”

May

  • Gaya K. Amarasinghe, PhD
    $59,999 from Alzheimer’s Association for “DEVi Engineered decoy viral inhibitors (DEVi) to prevent Tau spread by Lrp1”
  • Marco Colonna, MD
    $430,655 from NIH for “Soluble TREM2 regulation of microglial function in Alzheimer disease”
    $196,875 from NIH for “Impact of polyamines on ILC3 function at steady state and in preclinical model of colitis”
  • Brian Edelson, MD, PhD
    $176,889 from National Multiple Sclerosis Society for “T cell-intrinsic roles for the ZFP36 family proteins in MS and EAE”

June

  • Marco Colonna, MD
    $149,999 from Kenneth Rainin Foundation for “How intraepithelial TCRgd T cell subsets maintain intestinal homeostasis”
  • Brian Edelson, MD, PhD
    $319,584 from NIH for “Role of Intestinal Parasites on Regulating Immune Responses to Gut Antigens”
  • Ta-Chiang Liu, MD, PhD
    $149,999 from Kenneth Rainin Foundation for “Autophagy shapes Debaryomyces hansenii invasion in Crohn’s disease”
  • Kenneth Murphy, MD, PhD
    $559,854 from NIH for “Molecular Basis of cDC1 Development”
  • Steve Persaud, MD, PhD
    One-year, $70,000 Developmental Research Program award from the Washington University Specialized Program of Research Excellence (SPORE) in Leukemia for his project entitled: “Maximizing antileukemia effect and minimizing toxicity of antibody-based HSCT conditioning”

July

  • Robert Schreiber, PhD
    $401,129 from NIH for “Training in the Immunobiology and Molecular Cell Biology of Cancer”
  • Steven L. Teitelbaum, MD
    $1,000 from The Foundation For Barnes-Jewish Hospital for “Avioli Lecture Award”
    $39,413 for The Foundation For Barnes-Jewish Hospital for “Sonnenwirth Lecture Award”

August

  • Gaya K. Amarasinghe, PhD
    $393,750 from NIH for “Development and Characterization of Engineering Therapeutic Antibodies Against SARS-CoV-2”
  • Jonathan Kipnis, PhD
    $585,577 from NIH for “Aged T-cell-derived cytokines impact meningeal lymphatics and contribute to AD”
    $827,228 from NIH for “Neuroimmunology of AD and CAA with focus on innate immunity and lymphatics”
  • Katherine Schwetye, MD, PhD
    $410,984 from NIH for “Human in vivo stable isotope labeling kinetics (iSILK) to quantify brain amyloid plaque kinetics”

September

  • Eric Duncavage, MD
    $261,450 from NIH for “Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes”
  • Steve Persaud, MD, PhD
    One-year, $204,944 research supplement to Dr. John DiPersio’s R35 grant for the project entitled “Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies”
2021

July

  • Ali Ellebedy, PhD
    $110,000 from Bill & Melinda Gates Foundation for “Early Events and Role of FcR Pathways in Immunity to mRNA Vaccines”
  • Steven L. Teitelbaum, MD
    $10,000 from The Foundation For Barnes-Jewish Hospital for “Avioli Lecture Award”

August

  • Gautam Dantas, PhD
    $748,687 from CDC for “Interrogating the Phylogenomics and Mobilome of Colonizing Multidrug Resistant Organisms (MDROs) in Hospitalized Patients and Community-Dwellers in Pakistan”

September

  • Daved Fremont, PhD
    $1.39M from NIH for “B Cell Epitope Discovery and Mechanisms of Antibody Protection”
  • Jonathan Kipnis, PhD
    $249,999 from Carol and Gene Ludwig Family Foundation for “Exhibit B-3 Meningeal lymphatic vessels in Alzheimer’s disease”
  • Nima Mosammaparast, MD, PhD
    $45,000 from NIH for “Structural Cell Biology of DNA Repair Machines”

October

  • Kathleen Sheehan, PhD
    $300,000 from NGM Biopharmaceuticals for “Elucidating the Role of LAIR1 in Controlling Tumor Immunity”

November

  • Gautam Dantas, PhD
    $123,589 from bioMerieux for “Validation of bioMerieux EPISEQ CS and EPISEQ 16S using Wash U whole bacterial genomes and metagenomics 16S rRNA gene sequence databases”
  • Takeshi Egawa, MD, PhD
    $78,750 from NIH for “Developing tools to study relationship between oxidative stress in T cell dysfunction”
  • Jeffrey Gordon, MD
    $824,113 from Bill & Melinda Gates Foundation for “Maternal Microbiome directed therapeutic foods development”

December

  • Ali Ellebedy, PhD
    $735,765 from Moderna Therapeutics for “Defining the Cross-Reactivity and Durability of Human B Cell Responses to SARS-CoV-2 Variants-Based mRNA Vaccination”
    $1.13M from Moderna Therapeutics for “Defining the Diversity and Specificity of Human B Cell Response to Influenza Virus mRNA-Based Vaccines”
  • Scott Handley, PhD
    $52,838 from The Leona M. and Harry B. Helmsley Charitable Trust for “Anti-phage Antibodies in Stratifying Crohn’s Disease Diagnosis and Treatment Response”
  • Jonathan Kipnis, PhD
    $172,500 from Cure Alzheimer’s Fund for “Contribution of skull bone marrow-derived cells to Alzheimer’s disease”
    $300,000 from anonymous foundation for “Contribution of skull bone marrow-derived cells to Alzheimer’s disease”